Advanced search×

A patient-centred interdisciplinary palliative care programme for end-stage chronic respiratory diseases.

Daisy J A Janssen, Martijn A Spruit, Ton P G Alsemgeest, Joan D Does, Jos M G A Schols, and Emiel F M Wouters

Int J Palliat Nurs 16(4):189-94 (2010) PMID 20559181

Palliative care should be part of integrated care for patients with end-stage respiratory diseases. An intensive inpatient interdisciplinary palliative care programme has been developed for patients with end-stage respiratory diseases in the Netherlands. This programme consists of the management of daily symptoms and care needs to support patients and their families, and maintain or improve quality of life of these patients and their loved ones. This article presents case studies which describe the clinical course and management of three patients admitted to the programme: a 77-year-old woman who died from chronic obstructive pulmonary disease (COPD); a 60-year-old woman with end-stage COPD who improved her daily functioning and was discharged home after 3 months; and a 74-year-old woman who died of pulmonary fibrosis. This article describes the characteristics of the programme and shows the possible benefits of an intensive patient-centred interdisciplinary palliative care programme for patients with end-stage respiratory diseases. Palliative care programmes can be the final step in the chain of care for patients with respiratory diseases. Further research is necessary to study whether, and to what extent, a patient-centred interdisciplinary palliative care programme for end-stage respiratory diseases may improve health status, daily symptom burden, patient satisfaction and quality of dying.

Version: za2963e q8zaf q8zbe q8zc4 q8zdf q8zee q8zf1 q8zge

Similar articles you may find interesting…

  1. Improving quality of life for patients with terminal respiratory disease.
    Isaac M and Curtis JR

    Audio, Transactions of the IRE Profession... 3(6):597-605 (2009) PMID 20477350

    Chronic respiratory disease is an increasingly prevalent cause of life-limiting illness. Care for patients with terminal respiratory diseases has historically focused on disease-modifying therapies, many of which have little impact on life expectancy. This exclusive focus can detract from attention...
  2. A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project.
    Anke A Ries, Peter P Trottenberg, ... Lukas L Radbruch

    Palliat Med 26(4):294-304 (2012) PMID 21865295

    Adverse effects such as abdominal discomfort, fish belching, fish aftertaste, nausea and diarrhoea were reported with a low incidence. No serious adverse effects were documented, but adverse effects often had an impact on quality of life. This often limited dose escalations or even led to discontinu...
  3. Clinical outcomes and contributors to weight loss in a cancer cachexia clinic.
    Egidio E Del Fabbro, David D Hui, ... Eduardo E Bruera

    J Palliat Med 14(9):1004-8 (2011) PMID 21793729

    Patients had a high frequency of multiple S-NIS, hypogonadism, and hypermetabolism. A combination of simple pharmacological and nonpharmacological interventions improved appetite significantly, and increased weight in one third of patients who were able to return for follow-up. Cachexia clinics are...